← Back to headlines
Mainz Biomed Secures $6 Million Private Placement, Focuses on Pancreatic Cancer
Mainz Biomed has secured a $6 million private placement and is shifting its focus to a U.S. pancreatic cancer program.
17 Feb, 12:39 — 17 Feb, 12:39
ℹOnly 1 source covers this story
